Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-16-001648
Filing Date
2016-08-15
Accepted
2016-08-15 16:23:55
Documents
2
Group Members
BIHUA CHENCORMORANT GLOBAL HEALTHCARE GP, LLCCORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G 99594
2 JOINT FILING AGREEMENT exhibit1.htm EX-1 7680
  Complete submission text file 0000929638-16-001648.txt   108939
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LLC (Filed by) CIK: 0001583977 (see all company filings)

EIN.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 43334 7 MILE ROAD SUITE 1000 NORTHVILLE MI 48167
Business Address 43334 7 MILE ROAD SUITE 1000 NORTHVILLE MI 48167 248-980-6538
Gemphire Therapeutics Inc. (Subject) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89598 | Film No.: 161833075
SIC: 2834 Pharmaceutical Preparations